DongKook Pharmaceutical Co., Ltd.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Public
- Established
- 1992-01-01
- Employees
- 1.1K
- Market Cap
- -
- Website
- http://www.dkpharm.co.kr
Clinical Trials
10
Active:1
Completed:7
Trial Phases
4 Phases
Phase 1:4
Phase 3:2
Phase 4:1
+1 more phases
Drug Approvals
13
PHILIPPINES:13
Drug Approvals
- Prev
- 1
- 2
- Next
Clinical Trials
Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials
Phase 1
4 (40.0%)Not Applicable
3 (30.0%)Phase 3
2 (20.0%)Phase 4
1 (10.0%)Efficacy and Safety of DKF-MA102 in Patients With Prostate Cancer
- First Posted Date
- 2024-07-08
- Last Posted Date
- 2024-07-08
- Lead Sponsor
- Dongkook Pharmaceutical Co., Ltd.
- Target Recruit Count
- 154
- Registration Number
- NCT06490328
- Locations
- 🇰🇷
Ewha Womans University mokdong Hospital, Seoul, Korea, Republic of
Efficacy and Safety of DKM420 in Patients With Osteoarthritis of Knee
Not Applicable
Completed
- Conditions
- Osteoarthritis of Knee
- First Posted Date
- 2023-09-01
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Dongkook Pharmaceutical Co., Ltd.
- Target Recruit Count
- 250
- Registration Number
- NCT06021444
- Locations
- 🇰🇷
chung-Ang University Hospital, Seoul, Korea, Republic of
Efficacy and Safety of DKB-119 in Patients in Crow's Feet
Not Applicable
Active, not recruiting
- Conditions
- Crow's Feet
- First Posted Date
- 2023-09-01
- Last Posted Date
- 2023-09-13
- Lead Sponsor
- Dongkook Pharmaceutical Co., Ltd.
- Target Recruit Count
- 100
- Registration Number
- NCT06021418
- Locations
- 🇰🇷
Chungang-University Hospital, Seoul, Korea, Republic of
Pharmacokinetics and Safety of AmBisome and DKF-5122
Phase 1
Completed
- Conditions
- Invasive Fungal InfectionsNeutropenic Fever
- Interventions
- First Posted Date
- 2023-03-01
- Last Posted Date
- 2023-03-01
- Lead Sponsor
- Dongkook Pharmaceutical Co., Ltd.
- Target Recruit Count
- 38
- Registration Number
- NCT05749380
- Locations
- 🇰🇷
The Catholic University of Korea Seoul St. Mary's Hospital, Seoul, Seocho-gu, Korea, Republic of
Efficacy and Safety of a 'Graft/Prosthesis, Biomaterial (DKM410)' in the Treatment of Both Nasolabial Folds
Not Applicable
Completed
- Conditions
- Nasolabial Folds
- First Posted Date
- 2022-11-10
- Last Posted Date
- 2022-11-14
- Lead Sponsor
- Dongkook Pharmaceutical Co., Ltd.
- Target Recruit Count
- 82
- Registration Number
- NCT05612958
- Locations
- 🇰🇷
Chung-Ang University Hospital, Seoul, Korea, Republic of
- Prev
- 1
- 2
- Next
News
No news found